Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study

Patients with unresectable and advanced intrahepatic cholangiocarcinoma (ICC) usually have short survival due to a lack of effective treatment. This multicenter, single arm, open labeled, prospective study was conducted to evaluate the effectiveness and safety of sorafenib combined with best support...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiangji, Jia, Weidong, Huang, Zhiyong, Li, Xiangcheng, Xing, Baocai, Jiang, Xiaoqing, Li, Jun, Si, Anfeng, Yang, Tian, Gao, Chunfang, Lau, Wan Yee, Shen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370037/
https://www.ncbi.nlm.nih.gov/pubmed/27783997
http://dx.doi.org/10.18632/oncotarget.12825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370037/
https://www.ncbi.nlm.nih.gov/pubmed/27783997
http://dx.doi.org/10.18632/oncotarget.12825

Ejemplares similares